PATH
Menu

Filter browse results

Total results with these characteristics: 771

Region: Global

Page 2 of 39
Heat-Stable Sublingual Oxytocin for the Prevention and Treatment of Postpartum Hemorrhage

Part of the Technology Updates series, this fact sheet describes PATH's work to develop an oxytocin sublingual fast-dissolving tablet presentation that dissolves in less than ten seconds in the patient’s mouth without the need for additional water or diluent. Oxytocin in this type of presentation could potentially increase the reach and efficacy of this lifesaving medication to areas lacking access to skilled health workers, refrigeration, or safe injection equipment.

Publication date: May 2014

Region: Global

Part of series: Technology Updates

Magnesium Sulfate Dilution Bottle

Part of the Technology Updates series, this fact sheet describes PATH's work in adapting the concept of a dilution bottle to simplify the process of magnesium sulfate administration for the treatment of preeclampsia and eclampsia. A dilution bottle bottle can facilitate the safe calculation of recommended doses by obviating the need to remember complex equations for dilution.

Publication date: May 2014

Region: Global

Part of series: Technology Updates

Mobile Application for Dosing and Dilution of Magnesium Sulfate

Part of the Technology Updates series, this fact sheet describes PATH’s work in collaboration with the University of Washington to develop a mobile application for magnesium sulfate administration for the treatment of preeclampsia and eclampsia. The application includes a dosing calculator and a detailed checklist based on World Health Organization protocol and is designed specifically to address the challenges of correctly calculating the dosage.

Publication date: May 2014

Region: Global

Part of series: Technology Updates

Rectal Delivery of Magnesium Sulfate

Part of the Technology Updates series, this fact sheet describes PATH's work to develop a rectally administered magnesium sulfate (MgSO4) formulation that could simplify delivery and improve access to MgSO4 treatment in low-resource settings.

Publication date: May 2014

Region: Global

Part of series: Technology Updates

Rotavirus Disease and Vaccines in Eritrea

This fact sheet provides an overview of rotavirus disease and vaccines in Eritrea. It includes information about the tremendous burden of rotavirus diarrhea in Eritrean children, rotavirus diarrhea treatment and prevention strategies, and the effectiveness of rotavirus vaccines.

Publication date: May 2014

Region: Global

Part of series: Rotavirus disease and vaccines fact sheets

SILCS Launches in Early Markets

The SILCS diaphragm is a single-size contraceptive barrier designed to fit a broad range of women. This document describes product features and the steps that PATH and our commercialization partner, Kessel Marketing & Vertriebs GmbH, are taking as we build toward the introduction of SILCS in low-resource settings.

Publication date: May 2014

Region: Global

Supporting Effective Management of Preeclampsia/Eclampsia: Mobile Application for Dosing and Dilution of Magnesium Sulfate

Severe preeclampsia and eclampsia (PE/E) are among the leading causes of maternal death and disability worldwide. Magnesium sulfate is the treatment recommended by the World Health Organization, but it remains underutilized due to difficult administration. PATH designed a mobile application for dosing and dilution of magnesium sulfate to address the challenges of correctly calculating magnesium sulfate dosage given multiple concentrations and a complex dosing regimen.

Publication date: May 2014

Region: Global

Target Product Profile: HIV Self-Test Version 4.1: A White Paper on the Evaluation of Current HIV Rapid Tests and Development of Core Specifications for Next-Generation HIV Tests

This annotated target product profile (TPP) describes the desired characteristics of an HIV self-test and is a result of a review of currently available literature, interviews with key informants/stakeholders, laboratory-generated data on the performance of rapid tests, and early usability studies in Kenya, Malawi, and South Africa. The purpose of the TPP is to provide a common foundation for the development of HIV self-tests that contains sufficient detail to allow device developers and key stakeholders to understand the characteristics a test must have to be successful.

Author: Peck RB, Lim JM, Wellhausen JD, Lee AM, Valdez MM

Publication date: May 2014

Region: Global

The Arise Program: Enhancing HIV Prevention Programs for At-Risk Populations

With funding from the Canadian International Development Agency, PATH is working to address the information gap on how to best tailor and scale up proven HIV prevention strategies among at-risk populations through cost-effective interventions in India, Senegal, Uganda, Zambia, and Zimbabwe.

Publication date: April 2014

Region: Global

Cervical Cancer Action: 2007 to 2014 . . . and Beyond

Cervical Cancer Action is a global partnership chaired by PATH and aimed at reducing cervical cancer in high-burden, low-income countries. Seven years after its founding and eight years after human papillomavirus vaccines first became available, Cervical Cancer Action offers this snapshot of its accomplishments to date and its vision of the work ahead.

Publication date: April 2014

Region: Global

Cold Chain Equipment Inventories

Part of the Technology Updates series, this fact sheet describes PATH and our partners’ work to validate a new web-based cold chain equipment inventory (CCEI) tool, which is a module of the DHIS2 open-source software platform. This tool will provide opportunities for countries to integrate CCEI data into their national health management information systems.

Publication date: April 2014

Region: Global

Part of series: Technology Updates

Fighting Malaria Today and Tomorrow: PATH Works With Developing Countries to Achieve a Malaria-Free World

This fact sheet describes PATH's work to eliminate malaria, including expanding the use of lifesaving tools, identifying and developing better diagnostics and drugs, devising new strategies for malaria control, and accelerating the development of malaria vaccines.

Publication date: April 2014

Region: Global

Part of series: Areas of focus fact sheets

Low-Cost Lung Support Models for Newborns

Part of the Technology Updates series, this fact sheet describes PATH's work on low-cost respiratory support devices for newborns.

Publication date: April 2014

Region: Global

Part of series: Technology Updates

Oral Delivery Technologies

Part of the Technology Updates series, this fact sheet describes PATH's approach to technologies for oral delivery of vaccines.

Publication date: April 2014

Region: Global

Part of series: Technology Updates

Preventing and Managing Noncommunicable Diseases

This fact sheet provides an overview of PATH’s work in noncommunicable diseases (NCDs). Our goal is to reduce preventable morbidity and mortality by using innovation and technology to increase access to prevention and care for NCDs in low-resource settings.

Publication date: April 2014

Region: Global

Projecting Health

Part of the Technology Updates series, this fact sheet describes PATH's and our partners' work on a new approach to health education in resource-poor settings. Projecting Health, also known as Digital Public Health, uses customized educational videos developed and produced by local communities to effectively improve health knowledge and behaviors.

Publication date: April 2014

Region: Global

Part of series: Technology Updates

Rapid, Point-of-Care Test for Glucose-6 Phosphate Dehydrogenase Deficiency

Part of the Technology Updates series, this fact sheet describes PATH’s work with diagnostic developers and stakeholders from around the world to develop a rapid, point-of-care diagnostic test for glucose-6 phosphate dehydrogenase (G6PD) deficiency. A reliable test for G6PD at the point of care is essential to malaria elimination strategies.

Publication date: April 2014

Region: Global

Part of series: Technology Updates

Semisynthetic Artemisinin: Cross-Sector Partnership to Stabilize the Antimalarial Drug Supply

Artemisinin-based combination therapy is considered the gold standard treatment for malaria, but global demand has often outpaced production, and pricing has been volatile. With funding from the Bill & Melinda Gates Foundation, PATH and our partners set out to develop a new pharmaceutical manufacturing process to produce commercial volumes of high-quality, nonseasonal, and affordable artemisinin to supplement the plant-based supply. This poster, presented at the Bay Area World Malaria Day Symposium on April 25, 2014, presents key facts on malaria, the market for artemisinin, partner roles, and commercial production.

Publication date: April 2014

Region: Global

Technology Solutions by the Numbers

This fact sheet highlights PATH's health technology solutions from the past 30 years.

Publication date: April 2014

Region: Global

Closing the Gap to End Preventable Maternal and Newborn Deaths

Interventions across the continuum of care determine healthy outcomes for both mother and baby. This infographic highlights the critical role of access to family planning, nutrition, prenatal and obsteric care, medicines and technologies, and newborn care. The health and survival of women and newborns lays the foundation for healthy communities. A related policy brief describes the important role that donors and policymakers can play in making a significant global health impact through funding and supporting maternal and child health programs.

Publication date: March 2014

Region: Global

Page 2 of 39